Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.annonc.2022.11.011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Penile cancer: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.
ESMO Open
July 2024
Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.
• This ESMO CPG provides recommendations for diagnosis, staging, pathology, treatment and follow-up of penile cancer. • Algorithms for the management of primary penile tumours and inguinal lymph nodes are provided. • The author group encompasses a multidisciplinary group of experts from different institutions and countries in Europe.
View Article and Find Full Text PDFMerkel-cell carcinoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.
ESMO Open
May 2024
Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology Unit, University of Brescia, ASST Spedali Civili, Brescia, Italy.
• This ESMO Clinical Practice Guideline provides key recommendations for managing Merkel-cell carcinoma (MCC). • Recommendations are based on available scientific data and the multidisciplinary group of experts’ collective opinion. • The guideline covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up.
View Article and Find Full Text PDFOutcome of adrenocortical carcinoma patients included in early phase clinical trials: Results from the French network ENDOCAN-COMETE.
Eur J Cancer
August 2023
Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France; Unité de Recherche INSERM U900, Université Paris-Saclay, Saint-Cloud, France.
Background: At metastatic stage, treatment of adrenocortical carcinoma (ACC) relies in first line on mitotane therapy, combination of mitotane with locoregional therapies or cisplatin-based chemotherapy according to initial presentation. In second line, ESMO-EURACAN recommendations favour enrolment of patients in clinical trials investigating experimental therapies. However, the benefit of this approach remains unknown.
View Article and Find Full Text PDFSalivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up.
ESMO Open
December 2022
Service d'Oncologie Médicale, Institut Roi Albert II, Cliniques Universitaires Saint-Luc, Brussels; Institut de Recherche Clinique et Expérimentale, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.
• This ESMO–EURACAN Clinical Practice Guideline provides key recommendations for managing salivary gland cancer. • The guideline covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up. • Treatment algorithms for parotid, submandibular, sublingual and minor salivary gland cancer are provided.
View Article and Find Full Text PDFCorrigendum to "Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology volume 31 (2020) 1476-1490].
Ann Oncol
July 2023
Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, University of Brescia, ASST-Spedali Civili, Brescia, Italy.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!